目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T1540 | P450 Dopamine Receptor 5-HT Receptor Adrenergic Receptor AChR Norepinephrine Histamine Receptor | ||
Doxepin hydrochloride (Aponal) 是一种可口服的三环抗抑郁剂,是选择性组胺受体 H1拮抗剂。它也是 CYP450抑制剂,抑制 CYP450 2C19和 CYP450 1A2。 | |||
T0137 | Dopamine Receptor 5-HT Receptor Opioid Receptor Adrenergic Receptor Histamine Receptor | ||
Mirtazapine (6-Azamianserin) 是一种有效的具有口服活性的去甲肾上腺素能和特异性血清素能抗抑郁剂 (NaSSA)。它也是一种5-HT2、5-HT3、组胺 H1 受体和 α2-肾上腺素受体拮抗剂,pKi 值分别为 8.05、8.1、9.3 和 6.95。 | |||
T2371 | Others | ||
Emapunil (XBD-173) 是一种选择性的、口服有效的TSPO(一种线粒体苯二氮受体) 的配体。在多种动物模型中,它显示出抗焦虑和抗抑郁特性。 | |||
T0162 | Dopamine Receptor 5-HT Receptor Adrenergic Receptor AChR Histamine Receptor | ||
Quetiapine (ICI204636) 是5-HT 受体激动剂和多巴胺受体拮抗剂,对人5-HT1A 的 pEC50值为 4.77,对人 D2的 pIC50值为 6.33。它用于治疗精神分裂症,以及治疗与 I 型双相情感障碍相关的急性躁狂发作。它对人 D2、HT1、5-HT2A、5-HT2C 受体具有中高等亲和力,pKi 值为 7.25、5.74、7.54和5.55。 | |||
T3086 | Dopamine Receptor 5-HT Receptor | ||
Mesoridazine Besylate (Serentil) 是一种哌啶类精神安定药,属于称为吩噻嗪类的药物,用于治疗精神分裂症。它是硫利达嗪的代谢物。 | |||
T19916 | NOS | ||
TRIM (1-(2-Trifluoromethylphenyl)imidazole) 是一氧化氮合酶抑制剂。它在体外能够抑制小鼠小脑 nNOS (IC50:28.2 µM),以及大鼠肺 iNOS (IC50:27.0 µM)。它拥有抗焦虑以及抗抑郁的能力。 | |||
T22051 | Imidazoline Receptor | ||
BU 224 hydrochloride 是一种选择性的咪唑啉 I(2) 结合位点配体,具有镇痛和抗抑郁样活性。 | |||
T1445 | Melatonin Receptor 5-HT Receptor | ||
Agomelatine (Valdoxan) 是褪黑激素受体的强效激动剂和 5-羟色胺-2C (5-HT2C) 受体的拮抗剂,在猪和人 5-HT2C 克隆受体中pKi 分别为 6.4 和 6.2。 | |||
T0482 | 5-HT Receptor Serotonin Transporter | ||
Sertraline hydrochloride (Sertraline HCl) 是选择性 5- 羟色胺再吸收抑制剂类的抗抑郁剂,可用于多种疾病的研究,如重度抑郁症和强迫症。 | |||
T4274 | Dopamine Receptor 5-HT Receptor | ||
Melitracen hydrochloride (Thymeol hydrochloride) 是一种可口服的双相抗抑郁药和抗焦虑药。它可以通过突触前膜抑制去甲肾上腺素和5-羟色胺(5-HT)的吸收,从而诱导突触空间中单胺递质的增加。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-00859 | HTR1B Protein, Human, Recombinant (His) | Human | in vitro E. coli expression system | ||
G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances, such as lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Regulates the release of 5-hydroxytryptamine, dopamine and acetylcholine in the brain, and thereby affects neural activity, nociceptive processing, pain perception, mood and behavior. Besides, plays a role in vasoconstriction of cerebral arteries.
|
|||||
TMPH-00861 | HTR1D Protein, Human, Recombinant (His & KSI) | Human | E. coli | ||
G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Regulates the release of 5-hydroxytryptamine in the brain, and thereby affects neural activity. May also play a role in regulating the release of other neurotransmitters. May play a role in vasoconstriction.
|
|||||
TMPH-00860 | HTR1D Protein, Human, Recombinant (hFc) | Human | HEK293 | ||
G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Regulates the release of 5-hydroxytryptamine in the brain, and thereby affects neural activity. May also play a role in regulating the release of other neurotransmitters. May play a role in vasoconstriction.
|